Jeil Pharma Holdings Inc (KRX:002620)
9,100.00
+140.00 (1.56%)
Apr 29, 2026, 3:30 PM KST
Jeil Pharma Holdings Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 14,635 | -51,159 | -16,250 | -74,556 | -3,482 | Upgrade
|
| Depreciation & Amortization | 14,949 | 14,099 | 12,556 | 10,905 | 8,983 | Upgrade
|
| Loss (Gain) From Sale of Assets | -12.08 | -7.97 | -0.53 | -23.98 | -1,930 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 45,204 | 28,604 | 78,335 | 16,388 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5,175 | -5,586 | -2,916 | -6,271 | -20,857 | Upgrade
|
| Loss (Gain) on Equity Investments | -24,722 | -9,855 | -9,329 | -5,708 | -8,452 | Upgrade
|
| Stock-Based Compensation | 696.53 | 1,026 | 578.03 | 472.48 | 163.17 | Upgrade
|
| Provision & Write-off of Bad Debts | 558.49 | -682.67 | -2,423 | -308.41 | 1,669 | Upgrade
|
| Other Operating Activities | 28,900 | 26,151 | 13,309 | 2,014 | 6,516 | Upgrade
|
| Change in Accounts Receivable | 26,816 | -11,223 | -14,328 | -12,722 | 10,835 | Upgrade
|
| Change in Inventory | 4,868 | -3,266 | -12,170 | 1,347 | 9,341 | Upgrade
|
| Change in Accounts Payable | -50,188 | -7,721 | -9,849 | 3,358 | 10,024 | Upgrade
|
| Change in Other Net Operating Assets | -10,936 | 7,563 | 7,803 | -14,098 | -15,795 | Upgrade
|
| Operating Cash Flow | 390.26 | 4,542 | -4,416 | -17,256 | 13,403 | Upgrade
|
| Operating Cash Flow Growth | -91.41% | - | - | - | - | Upgrade
|
| Capital Expenditures | -8,283 | -4,340 | -6,223 | -15,462 | -23,688 | Upgrade
|
| Sale of Property, Plant & Equipment | 12.2 | 8.35 | 87.64 | 23.98 | 37,800 | Upgrade
|
| Sale (Purchase) of Intangibles | -1,045 | -2,523 | -3,571 | -5,948 | 91.43 | Upgrade
|
| Investment in Securities | -5,312 | 8,508 | -3,770 | 169.41 | -10,506 | Upgrade
|
| Other Investing Activities | -0 | 620.43 | 51.01 | 106.46 | 3,627 | Upgrade
|
| Investing Cash Flow | -14,628 | 2,274 | -13,425 | -21,110 | 7,325 | Upgrade
|
| Short-Term Debt Issued | 24,115 | 13,843 | 25,834 | 27,163 | - | Upgrade
|
| Long-Term Debt Issued | 5,000 | - | - | - | 12,288 | Upgrade
|
| Total Debt Issued | 29,115 | 13,843 | 25,834 | 27,163 | 12,288 | Upgrade
|
| Short-Term Debt Repaid | -16,500 | -13,000 | - | - | -42,477 | Upgrade
|
| Long-Term Debt Repaid | -938 | -5,254 | -4,084 | -6,377 | -7,146 | Upgrade
|
| Total Debt Repaid | -17,438 | -18,254 | -4,084 | -6,377 | -49,623 | Upgrade
|
| Net Debt Issued (Repaid) | 11,677 | -4,411 | 21,750 | 20,785 | -37,335 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 7,498 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -396.98 | -810.02 | Upgrade
|
| Dividends Paid | -183.17 | -1,134 | -1,134 | -1,475 | -1,590 | Upgrade
|
| Other Financing Activities | -280.72 | 19,762 | -0 | 26,001 | 20,000 | Upgrade
|
| Financing Cash Flow | 11,213 | 14,217 | 20,616 | 44,914 | -12,238 | Upgrade
|
| Foreign Exchange Rate Adjustments | -607.38 | 1,749 | -496.29 | -369.37 | -93.19 | Upgrade
|
| Net Cash Flow | -3,631 | 22,782 | 2,279 | 6,179 | 8,397 | Upgrade
|
| Free Cash Flow | -7,893 | 202.38 | -10,638 | -32,717 | -10,284 | Upgrade
|
| Free Cash Flow Margin | -1.20% | 0.03% | -1.32% | -4.13% | -1.35% | Upgrade
|
| Free Cash Flow Per Share | -513.98 | 13.19 | -692.99 | -2131.27 | -669.95 | Upgrade
|
| Cash Interest Paid | 7,593 | 8,051 | 9,044 | 4,891 | 2,592 | Upgrade
|
| Cash Income Tax Paid | 9,093 | 3,289 | 2,092 | -596.65 | 5,401 | Upgrade
|
| Levered Free Cash Flow | 2,341 | 11,675 | -19,889 | -20,230 | 7,866 | Upgrade
|
| Unlevered Free Cash Flow | 7,025 | 17,221 | -13,219 | -16,510 | 9,921 | Upgrade
|
| Change in Working Capital | -29,439 | -14,647 | -28,544 | -22,115 | 14,405 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.